InDevR, Inc.

About

InDevR, Inc. is a biotechnology company based in Boulder, Colorado, specializing in analytical technologies for vaccine and biotherapeutic development. Founded in 2003 by scientists Kathy Rowlen, John Birks, and Laura Kuck, the company employs 25 people and generates $5.6 million in revenue. InDevR focuses on enhancing the accuracy and efficiency of biopharmaceutical characterization through innovative analytical tools. Its product offerings include the VaxArray® Portfolio for multiplexed potency assays, the CypherOne System for automated hemagglutination assay interpretation, and earlier products like miPLEX and Vidia for pathogen detection. The company also provides analytical services and assay development support tailored for vaccine manufacturers and research institutions, ensuring compliance with regulatory standards. InDevR serves leading pharmaceutical firms and global research institutions, contributing to advancements in vaccine development and biotherapeutic manufacturing.